Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025ACS Chemical Neuroscience

Exploring Esketamine’s Therapeutic Role for Perinatal Depression via TASK-1 Tandem Pore Potassium Channels

View Full Paper
Ask AI
Bookmark
Share

Authors

LZLin ZhuCJChen JiXFXiaoxiao Feng

Discussion

Loading...

Member takes

Overview

Clinical trial showed esketamine reduces depression in postpartum women, highlighting TASK-1 channel involvement.

Key Points

  • Esketamine significantly lowers depression scores in postpartum women, suggesting its therapeutic potential.
  • Among 298 participants, the use of esketamine resulted in marked reductions in depressive symptoms.
  • Analysis involved both clinical trial data and experimental mouse models assessing neuroinflammation.
  • Findings underscore the importance of TASK-1 channels in mediating the antidepressant effects of esketamine.

Cite This Study

Zhu et al. (2025) studied this question.

synapsesocial.com/papers/68c1a12d54b1d3bfb60dc3ddhttps://doi.org/10.1021/acschemneuro.5c00535
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rapid Improvement of Post-Partum Depression With Subanesthetic Racemic Ketamine2024 · 2 citations
  2. 2Two-Pore-Domain Potassium (K2P-) Channels: Cardiac Expression Patterns and Disease-Specific Remodelling Processes2021 · 51 citations
  3. 3Psychiatric emergencies during pregnancy and puerperium in low - And middle-income countries2024 · 4 citations
  4. 4Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency2021 · 66 citations
  5. 5The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity2022 · 69 citations